Farms.com Home   News

Tighter Global Sugar Supplies Support Recent Price Increases

World raw sugar prices increased in the 2015/16 marketing year after a four-year decline from 2010/11. Projections for 2016/17 support higher prices continuing through 2017.

Projected human sugar consumption is expected to be greater than production for the second consecutive year, after a prolonged period of surplus production during the years of declining prices. Due to the global production deficit, global inventories are projected to be drawn down again in 2016/17, resulting in the lowest stocks-to-use ratio in more than 20 years.

Through the first two months of 2016/17, raw sugar prices have been 50 percent higher than the previous year, due in large part to the relatively tight supply and use market outlook. This chart draws from the Sugar and Sweeteners Outlook report published in December 2016.

Tighter global sugar supplies support recent price increases

Source:usda.gov


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.